Literature DB >> 219564

Viral serology (hepatitis B virus, cytomegalovirus, Epstein-Barr virus) and abnormal liver function tests in transfused patients with hereditary hemorrhagic diseases.

R E Enck, R F Betts, M R Brown, G Miller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 219564     DOI： 10.1046/j.1537-2995.1979.19179160263.x

Source DB:  PubMed          Journal:  Transfusion        ISSN： 0041-1132            Impact factor:   3.157


× No keyword cloud information.
  5 in total

1.  Abnormal B cell function in haemophiliacs and their relationship with factor concentrates administration.

Authors:  J A Brieva; J Sequi; J M Zabay; A Pardo; A Campos; M Luz de la Sen; A Bootello
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

2.  Lymphocyte subset ratios and factor VIII usage in haemophilia.

Authors:  A C Beddall; K Al-Rubei; M D Williams; F G Hill
Journal:  Arch Dis Child       Date:  1985-06       Impact factor: 3.791

3.  Lymphocytes of haemophilia patients treated with clotting factor concentrates display activation-linked cell-surface antigens.

Authors:  U Köller; O Majdic; K Liszka; H Stockinger; I Pabinger-Fasching; K Lechner; W Knapp
Journal:  Clin Exp Immunol       Date:  1985-03       Impact factor: 4.330

4.  Co-Infection of the Hepatitis C Virus With Other Blood-Borne and Hepatotropic Viruses Among Hemophilia Patients in Poland.

Authors:  Marta Kucharska; Malgorzata Inglot; Aleksandra Szymczak; Weronika Rymer; Malgorzata Zalewska; Krzysztof Malyszczak; Urszula Zaleska-Dorobisz; Malgorzata Kuliszkiewicz-Janus
Journal:  Hepat Mon       Date:  2016-07-23       Impact factor: 0.660

5.  Effective inactivation of a wide range of viruses by pasteurization.

Authors:  Albrecht Gröner; Connie Broumis; Randel Fang; Thomas Nowak; Birgit Popp; Wolfram Schäfer; Nathan J Roth
Journal:  Transfusion       Date:  2017-11-16       Impact factor: 3.157
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.